Quantcast

Hormone Therapy Increases Risk Of Ovarian Cancer

November 10, 2010

(Ivanhoe Newswire) — Menopause is an unavoidable change that every woman’s body goes through.  Even though hormone therapy is used to help them through the process, it may be doing more damage than most think.  Women planning on taking hormone therapy for the treatment of symptoms should be aware of the possible increased risk for ovarian cancer.

“This study is consistent with previous recommendations that say if women are going to take hormones they should only take them in the short term,” which Konstantinos Tsilidis, Ph.D., a postdoctoral fellow at the Cancer Epidemiology Unit at the University of Oxford was quoted as saying.

Tsilidis and colleagues examined the European Prospective Investigation into Cancer and Nutrition; this includes 126,920 women ““ 424 of which were diagnosed with ovarian cancer over nine years of follow-ups.

Though previous use of hormone therapy was not associated with increased risk, current use of hormone therapy was linked with a 29 percent increased risk.  Risk levels did not change by type of hormone therapy, specific hormonal constituents, regimens and routes of administration of hormone therapy, or by ovarian cancer histology.

SOURCE: The Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, 7 ““ 10 November 2010




comments powered by Disqus